Complete Filing Data
Serina Therapeutics, Inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of -$37.0 thousand for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Serina Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$19.2M | -$11.1M | $5.3M | -$10.5M | -$8.7M | -$10.9M | -$12.2M | -$7.5M | -$6.6M |
| Revenue From Contract With Customer Excluding Assessed Tax | $130.0K | $56.0K | $3.2M | $34.0K | $144.0K | $361.0K | $1.7M | $1.4M | $1.4M |
| Research And Development Expense | $13.2M | $7.5M | $2.4M | $1.0M | $1.5M | $3.7M | $5.9M | $5.8M | $5.8M |
| Operating Income Loss | -$24.0M | -$17.0M | -$3.1M | -$7.0M | -$7.9M | -$10.1M | -$12.6M | -$11.2M | -$6.7M |
| Operating Expenses | $24.2M | $17.1M | $6.3M | $7.0M | $8.2M | $10.4M | $14.0M | $12.3M | $9.7M |
| General And Administrative Expense | $11.0M | $9.6M | $3.9M | $6.0M | $6.7M | $6.7M | $8.1M | $5.6M | $3.9M |
| Nonoperating Income Expense | $4.8M | $5.8M | $8.4M | -$3.5M | -$649.0K | -$299.0K | $323.0K | $3.5M | $26.0K |
| Net Income Loss Attributable To Noncontrolling Interest | -$33.0K | -$66.0K | $0.00 | -$60.0K | -$3.0K | -$111.0K | -$230.0K | -$229.0K | -$57.0K |
| Gross Profit | $102.0K | $21.0K | $125.0K | $335.0K | $1.5M | $1.0M | $1.2M | ||
| Amortization Of Intangible Assets | $131.0K | $132.0K | $131.0K | $132.0K | $558.0K | $477.0K | $517.0K | ||
| Cost Of Revenue | $40.0K | $13.0K | $19.0K | $26.0K | $244.0K | $364.0K | $168.0K | ||
| Comprehensive Income Net Of Tax | -$19.2M | -$11.1M | -$10.5M | -$8.8M | -$10.9M | -$12.3M | $7.8M | $6.6M | |
| Other Nonoperating Income | $228.0K | $283.0K | $13.0K | $448.0K | $183.0K | $38.0K | |||
| Other Comprehensive Income Loss Net Of Tax | -$10.5M | -$8.8M | -$10.8M | -$12.1M | -$7.6M | -$6.6M | |||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$14.0K | $0.00 | -$143.0K | $74.0K | $71.0K | -$70.0K | $10.0K | ||
| Interest Expense | $4.9M | $3.3M | $1.1M | ||||||
| Interest Income Expense Nonoperating Net | -$1.1M | -$404.0K | $29.0K | $116.0K | -$12.0K | ||||
| Other Nonoperating Income Expense | $51.0K | $228.0K | $448.0K | $105.0K | $294.0K | ||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$33.0K | -$66.0K | -$111.0K | -$230.0K | $229.0K | $57.0K | |||
| Income Loss From Continuing Operations | -$10.5M | -$8.6M | -$10.4M | ||||||
| Income Loss From Continuing Operations Per Basic Share | -$0.28 | -$0.23 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$4.6M | -$6.4M | -$4.8M | $1.4M | $5.2M | -$15.0M | $1.8M | $808.0K | $1.7M | -$2.4M | -$2.6M | -$2.7M | -$2.0M | -$2.5M | -$2.1M | -$2.5M | -$2.7M | -$3.2M | -$3.2M | -$3.1M | -$3.1M | -$2.2M | -$1.9M | -$235.0K |
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $130.0K | $0.00 | $14.0K | $51.0K | $5.0K | $29.0K | $7.0K | $30.0K | $9.0K | $12.0K | $5.0K | $24.0K | $37.0K | $56.0K | $69.0K | $45.0K | $89.0K | $411.0K | $380.0K | $388.0K | $380.0K | $464.0K | $239.0K |
| Research And Development Expense | $3.7M | $3.2M | $3.0M | $2.4M | $1.6M | $1.1M | $603.0K | $479.0K | $399.0K | $162.0K | $259.0K | $396.0K | $275.0K | $481.0K | $324.0K | $653.0K | $935.0K | $1.2M | $1.4M | $1.7M | $1.3M | $1.3M | $1.4M | $1.6M |
| Operating Income Loss | -$6.4M | -$5.6M | -$5.9M | -$5.3M | -$3.9M | -$2.3M | -$1.5M | -$945.0K | -$962.0K | -$1.6M | -$1.6M | -$2.1M | -$1.7M | -$2.2M | -$2.2M | -$2.4M | -$2.4M | -$3.0M | -$3.3M | -$3.4M | -$3.1M | -$2.2M | -$2.1M | -$3.6M |
| Operating Expenses | $6.4M | $5.7M | $5.9M | $5.3M | $3.9M | $2.3M | $1.5M | $952.0K | $992.0K | $1.6M | $1.6M | $2.1M | $1.7M | $2.2M | $2.3M | $2.4M | $2.4M | $3.1M | $3.6M | $3.8M | -$3.4M | -$2.6M | $2.5M | $3.7M |
| General And Administrative Expense | $2.7M | $2.5M | $2.9M | $2.9M | $2.3M | $1.2M | $889.0K | $473.0K | $593.0K | $1.4M | $1.3M | $1.7M | $1.4M | $1.7M | $2.0M | $1.8M | $1.5M | $1.9M | $2.2M | $2.1M | $2.1M | $1.3M | $1.1M | $1.3M |
| Nonoperating Income Expense | $1.8M | -$897.0K | $1.0M | $6.7M | $9.0M | -$12.7M | $3.2M | $1.8M | $2.6M | -$886.0K | -$1.0M | -$655.0K | -$281.0K | -$270.0K | $194.0K | -$127.0K | -$106.0K | -$27.0K | $56.0K | $290.0K | -$16.0K | $17.0K | $183.0K | $3.2M |
| Net Income Loss Attributable To Noncontrolling Interest | -$10.0K | -$14.0K | -$9.0K | -$27.0K | -$27.0K | $0.00 | $0.00 | -$10.0K | -$8.0K | -$1.0K | -$1.0K | -$1.0K | -$22.0K | -$42.0K | -$35.0K | -$56.0K | -$66.0K | -$78.0K | -$34.0K | -$21.0K | -$86.0K | |||
| Gross Profit | $34.0K | $4.0K | $9.0K | $4.0K | $6.0K | $4.0K | $22.0K | $24.0K | $53.0K | $52.0K | $42.0K | $88.0K | $362.0K | $327.0K | $325.0K | $384.0K | $385.0K | $130.0K | ||||||
| Amortization Of Intangible Assets | $33.0K | $32.0K | $33.0K | $33.0K | $33.0K | $33.0K | $33.0K | $33.0K | $33.0K | $33.0K | $33.0K | $140.0K | $140.0K | $139.0K | $123.0K | $107.0K | $107.0K | |||||||
| Cost Of Revenue | $33.0K | $5.0K | $1.0K | $5.0K | $6.0K | $1.0K | $2.0K | $13.0K | $3.0K | $17.0K | $3.0K | $1.0K | $49.0K | $53.0K | $63.0K | -$4.0K | $79.0K | $109.0K | ||||||
| Comprehensive Income Net Of Tax | -$4.6M | $1.4M | -$3.3M | -$2.4M | -$2.6M | -$2.7M | -$2.0M | -$2.5M | -$2.2M | -$2.6M | -$2.7M | -$3.2M | -$3.2M | -$3.1M | -$3.2M | -$2.2M | -$2.0M | -$322.0K | ||||||
| Other Nonoperating Income | $47.0K | $87.0K | $3.0K | $4.0K | $3.0K | $2.0K | $4.0K | $3.0K | $4.0K | $48.0K | $257.0K | -$22.0K | $156.0K | |||||||||||
| Other Comprehensive Income Loss Net Of Tax | -$3.3M | -$2.4M | -$2.6M | -$2.7M | -$2.0M | -$2.5M | -$2.2M | -$2.5M | -$2.7M | -$3.2M | -$3.2M | -$3.1M | -$3.1M | -$2.1M | -$2.0M | -$236.0K | ||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$4.0K | $0.00 | -$143.0K | $11.0K | $37.0K | -$25.0K | $30.0K | $20.0K | $26.0K | $5.0K | -$45.0K | -$1.0K | ||||||||||||
| Interest Expense | $99.0K | $3.0M | $792.0K | $86.0K | $923.0K | $863.0K | $571.0K | $285.0K | ||||||||||||||||
| Interest Income Expense Nonoperating Net | -$863.0K | -$571.0K | -$285.0K | -$274.0K | -$243.0K | -$127.0K | -$65.0K | -$30.0K | $8.0K | $33.0K | $12.0K | $39.0K | $27.0K | $18.0K | ||||||||||
| Other Nonoperating Income Expense | $35.0K | $68.0K | $42.0K | $56.0K | $105.0K | $4.0K | -$84.0K | $4.0K | $4.0K | $437.0K | -$12.0K | $1.0K | $5.0K | $48.0K | $257.0K | -$28.0K | ||||||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$10.0K | -$27.0K | -$8.0K | -$22.0K | -$42.0K | -$35.0K | -$56.0K | -$66.0K | -$78.0K | -$34.0K | -$21.0K | -$86.0K | ||||||||||||
| Income Loss From Continuing Operations | -$2.4M | -$2.6M | -$2.7M | -$2.0M | -$2.5M | -$2.0M | -$2.5M | -$2.4M | -$3.0M | |||||||||||||||
| Income Loss From Continuing Operations Per Basic Share | -$0.06 | -$0.07 | -$0.07 | -$0.05 | -$0.07 | -$0.05 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$37.0K | $641.0K | -$32.3M | -$37.8M | -$11.8M | -$5.1M | $2.2M | $8.2M | $7.3M | -$22.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $3.1M | $3.7M | $7.6M | $532.0K | $634.0K | $577.0K | $2.5M | $6.7M | ||
| Cash And Cash Equivalents At Carrying Value | $3.1M | $3.7M | $7.6M | $645.0K | $584.0K | $527.0K | $259.0K | |||
| Retained Earnings Accumulated Deficit | -$63.5M | -$44.3M | -$33.2M | -$116.2M | -$105.7M | -$97.1M | -$86.2M | -$66.6M | ||
| Liabilities And Stockholders Equity | $7.0M | $6.7M | $9.0M | $3.2M | $3.2M | $3.9M | $7.4M | $9.6M | ||
| Liabilities | $7.0M | $6.2M | $4.9M | $20.6M | $15.0M | $9.3M | $4.8M | $1.3M | ||
| Assets Current | $6.1M | $5.7M | $7.6M | $2.5M | $2.2M | $2.3M | $4.1M | $7.6M | ||
| Assets | $7.0M | $6.7M | $9.0M | $3.2M | $3.2M | $3.9M | $7.4M | $9.6M | ||
| Common Stock Value | $1.0K | $1.0K | $0.00 | $4.0K | $4.0K | $4.0K | $3.0K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$616.0K | -$3.9M | $7.1M | $61.0K | $57.0K | -$1.9M | -$4.3M | |||
| Liabilities Current | $3.6M | $2.4M | $1.4M | $10.1M | $9.0M | $5.4M | $3.3M | |||
| Prepaid Expense And Other Assets Current | $3.0M | $2.0M | $0.00 | $1.8M | $1.6M | $1.4M | $1.3M | $111.0K | ||
| Minority Interest | $0.00 | -$133.0K | $0.00 | -$103.0K | -$43.0K | -$280.0K | $399.0K | $1.0M | ||
| Accounts Payable And Accrued Liabilities Current | $1.0M | $771.0K | $1.7M | $1.6M | $768.0K | |||||
| Intangible Assets Net Excluding Goodwill | $738.0K | $870.0K | $1.6M | $2.2M | $1.9M | |||||
| Accounts Receivable Net Current | $57.0K | $4.0K | $25.0K | $326.0K | $363.0K | $107.0K | ||||
| Property Plant And Equipment Net | $465.0K | $501.0K | $573.0K | $1.1M | $129.0K | |||||
| Loans Payable Current | $7.6M | $7.1M | $436.0K | |||||||
| Deposits Assets Noncurrent | $50.0K | $111.0K | $35.0K | |||||||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $35.4M | ||||||||
| Restricted Cash Noncurrent | $50.0K | $50.0K | ||||||||
| Long Term Loans Payable | $10.5M | $6.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $1.8M | $1.8M | $1.7M | -$13.8M | -$16.4M | -$4.3M | -$27.5M | -$22.2M | -$36.1M | -$37.8M | -$15.1M | -$13.2M | -$11.5M | -$9.9M | -$8.3M | -$6.1M | -$3.7M | -$2.4M | -$739.0K | $4.3M | $6.7M | $9.3M | $7.4M | $10.7M | $12.2M | $9.0M | $8.3M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $8.6M | $6.0M | $4.3M | $3.2M | $6.1M | $8.8M | $7.6M | $8.7M | $9.9M | $516.0K | $752.0K | $498.0K | $781.0K | $665.0K | $859.0K | $1.2M | $1.1M | $568.0K | $3.9M | $5.9M | $8.6M | $8.8M | $11.4M | $7.4M | ||||||
| Cash And Cash Equivalents At Carrying Value | $8.6M | $6.0M | $4.3M | $3.2M | $6.1M | $8.7M | $397.0K | $261.0K | $280.0K | $466.0K | $702.0K | $448.0K | $731.0K | $615.0K | $809.0K | $1.1M | $1.0M | $468.0K | $2.4M | $3.8M | $5.8M | $8.6M | $6.7M | $8.5M | $7.4M | |||||
| Retained Earnings Accumulated Deficit | -$60.2M | -$55.6M | -$49.1M | -$127.6M | -$122.2M | -$119.5M | -$113.5M | -$111.1M | -$108.5M | -$103.6M | -$101.6M | -$99.2M | -$94.6M | -$92.1M | -$89.4M | -$83.5M | -$80.3M | -$77.2M | -$74.1M | |||||||||||
| Liabilities And Stockholders Equity | $12.4M | $8.9M | $6.7M | $7.4M | $10.7M | $10.9M | $12.2M | $12.3M | $12.5M | $2.0M | $2.6M | $2.7M | $2.4M | $2.5M | $3.2M | $4.2M | $4.8M | $5.1M | $8.2M | $10.3M | $12.3M | $10.7M | ||||||||
| Liabilities | $10.8M | $7.3M | $5.2M | $21.3M | $27.1M | $15.2M | $3.9M | $34.6M | $32.5M | $17.2M | $15.8M | $14.3M | $12.4M | $10.8M | $9.3M | $7.9M | $6.9M | $5.5M | $3.2M | $2.9M | $2.3M | $2.4M | ||||||||
| Assets Current | $11.5M | $8.0M | $5.8M | $5.4M | $8.9M | $8.9M | $1.1M | $1.4M | $1.7M | $1.2M | $1.7M | $1.8M | $1.5M | $1.6M | $2.1M | $1.9M | $2.1M | $2.1M | $4.7M | $6.7M | $9.6M | $7.9M | ||||||||
| Assets | $12.4M | $8.9M | $6.7M | $7.4M | $10.7M | $10.9M | $12.2M | $12.3M | $12.5M | $2.0M | $2.6M | $2.7M | $2.4M | $2.5M | $3.2M | $4.2M | $4.8M | $5.1M | $8.2M | $10.3M | $12.3M | $10.7M | ||||||||
| Common Stock Value | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $595.0K | $1.1M | $9.4M | -$136.0K | $282.0K | -$1.9M | $1.9M | |||||||||||||||||||||||
| Liabilities Current | $8.8M | $3.6M | $2.4M | $13.5M | $12.6M | $14.1M | $3.2M | $24.5M | $22.5M | $8.8M | $9.1M | $10.1M | $6.6M | $5.3M | $3.9M | $4.9M | $4.7M | $5.5M | $2.9M | $2.6M | $2.4M | |||||||||
| Prepaid Expense And Other Assets Current | $2.9M | $2.0M | $1.5M | $2.2M | $2.8M | $166.0K | $673.0K | $1.1M | $1.5M | $720.0K | $1.0M | $1.4M | $720.0K | $930.0K | $1.3M | $581.0K | $836.0K | $1.2M | $688.0K | $659.0K | $856.0K | $1.0M | ||||||||
| Minority Interest | -$166.0K | -$156.0K | -$142.0K | -$54.0K | -$30.0K | -$109.0K | -$121.0K | -$111.0K | -$45.0K | -$44.0K | -$44.0K | -$42.0K | -$42.0K | -$41.0K | -$95.0K | $322.0K | $364.0K | $604.0K | $660.0K | $706.0K | $784.0K | |||||||||
| Accounts Payable And Accrued Liabilities Current | $2.0M | $4.0M | $1.2M | $1.7M | $961.0K | $1.3M | $792.0K | $682.0K | $1.1M | $924.0K | $1.3M | $1.2M | $1.8M | $1.8M | $2.2M | $1.8M | $1.6M | $1.3M | $1.4M | |||||||||||
| Intangible Assets Net Excluding Goodwill | $509.0K | $541.0K | $574.0K | $0.00 | $640.0K | $673.0K | $705.0K | $771.0K | $804.0K | $837.0K | $902.0K | $935.0K | $968.0K | $1.7M | $1.9M | $2.0M | $2.3M | $2.4M | $2.6M | $2.7M | ||||||||||
| Accounts Receivable Net Current | $65.0K | $67.0K | $6.0K | $6.0K | $1.0K | $12.0K | $24.0K | $11.0K | $48.0K | $241.0K | $235.0K | $366.0K | $234.0K | $208.0K | $206.0K | $131.0K | ||||||||||||||
| Property Plant And Equipment Net | $580.0K | $588.0K | $484.0K | $519.0K | $540.0K | $564.0K | $442.0K | $681.0K | $898.0K | $1.0M | $951.0K | $84.0K | $90.0K | |||||||||||||||||
| Loans Payable Current | $10.5M | $10.4M | $9.7M | $0.00 | $1.5M | $22.9M | $20.0M | $7.3M | $435.0K | |||||||||||||||||||||
| Deposits Assets Noncurrent | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $100.0K | $100.0K | $111.0K | $193.0K | $196.0K | $19.0K | $19.0K | |||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $0.00 | $36.4M | $36.4M | $35.4M | $35.4M | |||||||||||||||||||||||
| Restricted Cash Noncurrent | $50.0K | $50.0K | $50.0K | $0.00 | $50.0K | $50.0K | $50.0K | $50.0K | ||||||||||||||||||||||
| Long Term Loans Payable | $693.0K | $693.0K | $693.0K | $0.00 | $693.0K | $10.1M | $10.0M | $8.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $2.6M | $25.0K | $760.0K | $999.0K | $909.0K | $1.9M | $1.3M | $114.0K | |
| Financing Cash Flow * | $17.4M | $13.2M | $10.1M | $6.0M | $7.2M | $6.0M | $6.3M | $6.0M | $13.3M |
| Investing Cash Flow * | -$59.0K | -$22.0K | -$504.0K | $666.0K | -$20.0K | -$361.0K | $1.3M | $5.0K | |
| Operating Cash Flow * | -$18.0M | -$17.1M | -$2.5M | -$5.9M | -$7.9M | -$7.8M | -$10.2M | -$8.0M | -$6.3M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$673.0K | $1.9M | -$16.0K | -$896.0K | -$760.0K | -$663.0K | -$473.0K | $293.0K | -$10.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $1.2M | $144.0K | -$772.0K | $382.0K | $169.0K | $648.0K | $267.0K | ||
| Increase Decrease In Accounts And Other Receivables | $53.0K | -$21.0K | -$128.0K | $30.0K | $232.0K | $24.0K | -$322.0K | ||
| Increase Decrease In Other Current Liabilities | $18.0K | $0.00 | -$4.0K | -$4.0K | -$79.0K | -$577.0K | -$119.0K | ||
| Increase Decrease In Insurance Liabilities | -$1.1M | -$983.0K | -$921.0K | -$713.0K | -$599.0K | ||||
| Proceeds From Lines Of Credit | $0.00 | $3.0M | $0.00 | $6.0M | $7.0M | $5.7M | $1.8M | ||
| Increase Decrease In Due To Related Parties | $69.0K | $255.0K | $15.0K | -$68.0K | -$128.0K | ||||
| Payments To Acquire Property Plant And Equipment | $59.0K | $22.0K | $20.0K | $641.0K | $21.0K | $1.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $956.0K | $53.0K | $2.0K | $239.0K | $272.0K | $286.0K | $178.0K | $227.0K | $252.0K | $252.0K | $491.0K | $515.0K | $481.0K | $210.0K | $231.0K | $145.0K |
| Financing Cash Flow * | $4.9M | $2.7M | $10.1M | $1.5M | $2.2M | $185.0K | $4.5M | $737.0K | ||||||||
| Investing Cash Flow * | $0.00 | -$14.0K | -$10.0M | $666.0K | -$4.0K | -$3.0K | $2.4M | |||||||||
| Operating Cash Flow * | -$4.3M | -$1.6M | -$709.0K | -$1.6M | -$2.6M | -$2.1M | -$2.6M | -$2.0M | ||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$458.0K | $57.0K | -$1.0K | -$243.0K | -$117.0K | -$201.0K | $64.0K | $29.0K | ||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $644.0K | $235.0K | $207.0K | -$346.0K | $345.0K | -$52.0K | $282.0K | |||||||||
| Increase Decrease In Accounts And Other Receivables | $3.0K | -$25.0K | -$105.0K | -$11.0K | $75.0K | -$53.0K | ||||||||||
| Increase Decrease In Other Current Liabilities | $3.0K | $6.0K | -$1.0K | -$54.0K | -$128.0K | |||||||||||
| Increase Decrease In Insurance Liabilities | -$353.0K | -$325.0K | -$304.0K | -$314.0K | ||||||||||||
| Proceeds From Lines Of Credit | $0.00 | $2.4M | $11.5M | $1.5M | $2.0M | |||||||||||
| Increase Decrease In Due To Related Parties | $61.0K | $19.0K | $117.0K | $8.0K | -$150.0K | |||||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $14.0K | $4.0K | $3.0K | $1.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.91 | -$1.51 | $0.73 | -$9.70 | -$0.23 | -$0.29 | -$0.33 | -$0.21 | -$0.21 |
| Common Stock Shares Outstanding | 10.8M | 9.4M | 2.4M | 1.1M | 37.9M | 37.7M | 37.6M | 33.8M | |
| Common Stock Shares Authorized | 40.0M | 40.0M | 40.0M | 200.0M | 100.0M | 100.0M | 100.0M | 100.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Earnings Per Share Basic | $-1.91 | $-1.51 | $2.36 | $-9.70 | $-0.23 | ||||
| Common Stock Shares Issued | 10.8M | 9.4M | 2.4M | 1.1M | 37.9M | 37.7M | 37.6M | 33.8M | |
| Weighted Average Number Of Shares Outstanding Basic | 10.2M | 7.4M | 2.2M | 1.1K | 37.9M | ||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 10.2M | 7.4M | 7.4M | 1.1K | |||||
| Preferred Stock Shares Outstanding | 965.0K | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Issued | 965.0K | 0.00 | 0.00 | 0.00 | |||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 37.9M | 37.7M | 37.3M | 34.9M | 30.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.45 | -$0.66 | -$0.49 | $0.13 | $0.51 | -$5.38 | $0.23 | $0.11 | $0.20 | -$0.06 | -$0.07 | -$0.05 | -$0.07 | -$0.06 | -$0.07 | -$0.07 | -$0.08 | -$0.09 | -$0.08 | -$0.09 | -$0.06 | -$0.06 | -$0.01 | |||||
| Common Stock Shares Outstanding | 10.5M | 10.1M | 9.9M | 8.9M | 8.8M | 38.0M | 38.0M | 38.0M | 37.9M | 37.9M | 37.9M | 37.9M | 37.9M | 37.9M | 37.7M | 37.7M | 37.7M | 37.6M | 37.6M | 37.6M | 35.8M | |||||||
| Common Stock Shares Authorized | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 200.0M | 200.0M | 200.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | |||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Earnings Per Share Basic | $-0.45 | $-0.66 | $-0.49 | $0.16 | $0.61 | $-5.38 | $0.80 | $0.37 | $0.77 | $-0.06 | $-0.07 | $-0.07 | $-0.05 | $-0.07 | $-0.06 | |||||||||||||
| Common Stock Shares Issued | 10.5M | 10.1M | 9.9M | 8.9M | 8.8M | 8.4M | 38.0M | 38.0M | 38.0M | 37.9M | 37.9M | 37.9M | 37.9M | 37.9M | 37.9M | 37.7M | 37.7M | 37.7M | 37.6M | 37.6M | 37.6M | 35.8M | ||||||
| Weighted Average Number Of Shares Outstanding Basic | 10.3M | 10.0M | 9.8M | 8.9M | 8.5M | 2.8M | 2.2M | 2.2K | 2.2M | 37.9K | 37.9K | 37.9M | 37.9M | 37.9K | ||||||||||||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | |||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 10.3M | 10.0M | 9.8M | 10.8M | 10.2M | 2.8M | 7.6M | 7.4K | 8.6M | 37.9K | 37.9K | 37.9M | 37.7M | |||||||||||||||
| Preferred Stock Shares Outstanding | 965.0K | 965.0K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||
| Preferred Stock Shares Issued | 965.0K | 965.0K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 37.9M | 37.9M | 37.7M | 37.7M | 37.7M | 37.7M | 37.6K | 37.6M | 36.1K | 35.8K | 34.2M | 33.8M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $58.5M | $45.0M | $883.0K | $99.0M | $93.9M | $91.8M | $88.4M | $73.8M | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $3.8M | $2.6M | $25.0K | $760.0K | $1.0M | $933.0K | $1.9M | $1.3M | $114.0K |
| Fair Value Adjustment Of Warrants | -$4.3M | -$13.2M | -$1.1M | $225.0K | |||||
| Amortization Of Financing Costs | $58.0K | $345.0K | $0.00 | $3.1M | $1.1M | $487.0K | $54.0K | ||
| Interest Paid Net | $17.0K | $0.00 | $27.0K | $14.0K | $13.0K | $12.0K | $12.0K | $11.0K | $9.0K |
| Stock Issued During Period Value Restricted Stock Award Gross | $29.0K | -$1.0K | -$4.0K | -$7.0K | -$9.0K | ||||
| Change In Fair Value Of Convertible Promissory Notes | $0.00 | $7.0M | -$5.4M | ||||||
| Stock Issued1 | $0.00 | $36.4M | $0.00 | $8.0K | $16.0K | $37.0K | $56.0K | $240.0K | |
| Due To Related Parties Current | $141.0K | $70.0K | $2.0M | $210.0K | |||||
| Stock Issued During Period Value Stock Options Exercised | $15.0K | $12.0K | $15.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $57.0M | $52.4M | $50.8M | $100.0M | $100.0M | $99.6M | $98.4M | $97.9M | $96.9M | $93.7M | $93.4M | $93.1M | $90.9M | $89.6M | $88.6M | $87.8M | $87.0M | $86.5M | $81.5M | |||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $999.0K | $890.0K | $956.0K | $1.1M | $458.0K | $53.0K | $40.0K | $23.0K | $2.0K | $209.0K | $198.0K | $239.0K | ||||||||||
| Fair Value Adjustment Of Warrants | -$1.0M | $956.0K | -$989.0K | -$6.7M | -$9.3M | -$5.6M | -$596.0K | -$291.0K | -$172.0K | -$35.0K | $168.0K | $87.0K | ||||||||||
| Amortization Of Financing Costs | $0.00 | $22.0K | $1.1M | $544.0K | $267.0K | $47.0K | ||||||||||||||||
| Interest Paid Net | $1.0K | |||||||||||||||||||||
| Stock Issued During Period Value Restricted Stock Award Gross | $29.0K | -$1.0K | -$1.0K | -$1.0K | -$1.0K | |||||||||||||||||
| Change In Fair Value Of Convertible Promissory Notes | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $7.0M | -$2.6M | -$1.6M | -$294.0K | |||||||||||||
| Stock Issued1 | $0.00 | $36.4M | ||||||||||||||||||||
| Due To Related Parties Current | $59.0K | $7.0M | $6.7M | $5.6M | $3.6M | $2.0M | $1.9M | $1.8M | $1.8M | $319.0K | $62.0K | $140.0K | $132.0K | |||||||||
| Stock Issued During Period Value Stock Options Exercised | $8.0K | $1.0K | $1.0K | $86.0K | $4.0K | $13.0K | $1.0K |
Most recent annual filing with the SEC: March 25, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.